Thermo Fisher (TMO) Acquires One Lambda for $925M

July 16, 2012 6:32 AM EDT Send to a Friend
Thermo Fisher Scientific Inc. (NYSE: TMO) signed a definitive agreement to acquire One Lambda, the leader in transplant diagnostics, for $925 million in cash.

The purchase price includes the cost of a three-year retention program established by One Lambda for the benefit of key employees, amounts payable to certain shareholders for noncompetition agreements, and a one-year earn-out provision based on the achievement of certain financial targets.

The transaction, which is expected to be completed in the fourth quarter of 2012, is expected to be immediately accretive upon close and add $0.09 to $0.11 to Thermo Fisher’s 2013 adjusted earnings per share.


Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here



You May Also Be Interested In


Related Categories

Hot M&A, Mergers and Acquisitions

Related Entities

Earnings

Add Your Comment